Trial intelligence / Profile preview

pTTL in Advanced Colorectal Cancer

NCT05908643Phase 2Active, not recruiting

Sponsor
Neogap Therapeutics
Start
Mar 2023
Primary completion
Dec 2030
Modality
Adoptive Cell Transfer
Countries
1
01

Overview

A Phase 2 trial of pTTL in colorectal cancer (CRC), sponsored by Neogap Therapeutics. Started Mar 2023; status: active, not recruiting.

02

Drugs

pTTL
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT05908643.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05908643.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call